Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Sirav B et al. | 2021 | animal, rat/Wistar albino (healthy and diabetic) | RF field, magnetic field, 50/60 Hz, low frequency | - |
| Svedenstal BM et al. | 1998 | animal, mouse/CBA/Ca and CBA/s, whole body | magnetic field, low frequency, 50/60 Hz, intermediate frequency | 14–15 µT |
| Svedenstal BM et al. | 1999 | animal, mouse/CBA/Ca, whole body | magnetic field, 50/60 Hz, power transmission line | 8 µT |
| Tekam CKS et al. | 2023 | intact cell/cell culture, C6 glial cells, animal, rat/Wistar | 50/60 Hz, magnetic field, signals/pulses | - |
| Thomson RA et al. | 1988 | animal, mouse/DBA/2 (partially implanted with P388 leukemia cells), whole body | magnetic field, 50/60 Hz | 1.4–500 µT |
| Tofani S et al. | 2002 | animal, mouse/CD-1 nu-nu (nude), whole body | magnetic field, static magnetic field, 50/60 Hz | 1–5.5 mT |
| Torres-Duran PV et al. | 2007 | animal, rat/Wistar | magnetic field, 50/60 Hz | 2.4 mT |
| Tunik S et al. | 2013 | animal, rat/Wistar albino, whole body | magnetic field, signals/pulses, 50/60 Hz | 1.5 mT |
| Vignola MB et al. | 2012 | animal, rat/Wistar, whole body | magnetic field, signals/pulses, 50/60 Hz, therapeutic/medical device | 20 mT |
| Vornoli A et al. | 2022 | animal, rat/Sprague Dawley | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
